TrialNature medicine2024

Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results.

Jerry R Mendell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.